4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-012221
Chief Executive Officer sold 5,675 shares at $232.41 ($1,318,947)
- Chief Executive Officer acquired 5,675 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-18 | Exercise or conversion : show line 1 in the form | +5,675 | $57.76 | $327,788 | 410,904 | D |
| 2022-04-18 | Sale : show line 2 in the form | −5,675 | $232.41 | $1,318,947 | 405,229 | D |
| Open-market sales · 5,675 sh · avg $232.41 · $1,318,947 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-18 | Exercise or conversion : show line 3 in the form ResMed Common Stock Options | −5,675 | 111,290 | D |
Loading xslF345X03/form4.xml…